Video Experimental Relacionado
Updated: Mar 24, 2026
08:56
Development of New Therapeutic Applications Using Microfluidics
Published on: October 1, 2007
5.7K
La comunicación en el desarrollo de fármacos: "traducir" el descubrimiento científico
Jeff Settleman1, Robert L Cohen1
1Calico Life Sciences, 1170 Veterans Boulevard, South San Francisco, CA 94080, USA.
Cell
|March 12, 2016
Resumen
Desarrollar nuevos medicamentos es difícil. Este comentario describe las estrategias de comunicación esenciales para traducir los descubrimientos biológicos en terapias farmacológicas aprobadas, abordando los principales desafíos y oportunidades.
Área de la Ciencia:
- Descubrimiento y desarrollo de fármacos
- Ciencias traslacionales
- Investigación farmacéutica
Sus antecedentes:
- El desarrollo de nuevas terapias para mejorar la salud humana y la longevidad es un desafío científico y logístico complejo.
- La traducción de los descubrimientos biológicos básicos en fármacos clínicamente efectivos requiere superar obstáculos significativos.
Objetivo del estudio:
- Identificar los elementos críticos de comunicación para el desarrollo exitoso de fármacos.
- Discutir los desafíos y las oportunidades para traducir los hallazgos biológicos en terapias aprobadas.
Principales métodos:
- Este comentario sintetiza la comprensión actual de la tubería de desarrollo de medicamentos.
- Analiza las estrategias de comunicación esenciales para la colaboración interdisciplinaria.
Principales resultados:
- La comunicación eficaz es crucial para cerrar la brecha entre la investigación biológica y la aplicación clínica.
- Los elementos clave de comunicación incluyen el intercambio claro de datos, la alineación de las partes interesadas y la navegación reglamentaria.
Conclusiones:
- La optimización de las vías de comunicación puede acelerar la traducción de investigaciones prometedoras en medicamentos que salvan vidas.
- Abordar los desafíos de la comunicación es vital para avanzar en la innovación farmacéutica y mejorar los resultados de los pacientes.
Videos de Conceptos Relacionados
01:26Drug Discovery: Overview
12.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.9K
01:28Preclinical Development: Overview
6.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.4K
01:26Drug Administration and Therapy Phases: Overview
1.7K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.7K
01:11Clinical Trials: Overview
5.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.4K
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
418
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
418
01:28Biopharmaceutics and Pharmacokinetics: Overview
4.9K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
4.9K